PlainRecalls
FDA Devices Moderate Class II Terminated

ATTUNE REVISION POSTERIOR FEMORAL AUGMENT SZ 9 12MM-intended as a Component in total knee arthroplasty (TKA) revision surgeries Product Number: 154909003

Reported: February 16, 2022 Initiated: January 5, 2022 #Z-0631-2022

Product Description

ATTUNE REVISION POSTERIOR FEMORAL AUGMENT SZ 9 12MM-intended as a Component in total knee arthroplasty (TKA) revision surgeries Product Number: 154909003

Reason for Recall

May have adhesive residue on the posterior surface of the femoral augment, if undetected prior to implantation, soft tissue irritation and/or infection may occur.

Details

Recalling Firm
DePuy Orthopaedics, Inc.
Units Affected
6 units
Distribution
US Nationwide distribution in the states of TN, TX.
Location
Warsaw, IN

Frequently Asked Questions

What product was recalled?
ATTUNE REVISION POSTERIOR FEMORAL AUGMENT SZ 9 12MM-intended as a Component in total knee arthroplasty (TKA) revision surgeries Product Number: 154909003. Recalled by DePuy Orthopaedics, Inc.. Units affected: 6 units.
Why was this product recalled?
May have adhesive residue on the posterior surface of the femoral augment, if undetected prior to implantation, soft tissue irritation and/or infection may occur.
Which agency issued this recall?
This recall was issued by the FDA Devices on February 16, 2022. Severity: Moderate. Recall number: Z-0631-2022.